Overview Dividends

(HWKN) Hawkins - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4202611095

Chemicals, Ingredients, Equipment, Services,

EPS (Earnings per Share)

EPS Growth (3y CAGR): 31.66%
EPS Trend (3y Corr): 52.7%

Last SUE: -1.05σ
Qual. Beats: 0

Revenue

Revenue Growth (3y CAGR): 9.37%
Revenue Trend (3y Corr): 65.6%

Last SUE: -0.34σ
Qual. Beats: 0

Risk via 10d forecast
Volatility	39.7%
Value at Risk 5%th	58.7%
Relative Tail Risk	-10.19%

Reward TTM
Sharpe Ratio	-0.04
Alpha	-14.02

Character TTM
Hurst Exponent	0.453
Beta	0.881
Beta Downside	0.535

Drawdowns 3y
Max DD	34.79%
Mean DD	6.89%
Median DD	4.87%

Description: HWKN Hawkins November 09, 2025

Hawkins, Inc. (NASDAQ:HWKN) is a U.S.–based provider of water-treatment chemicals, industrial specialty chemicals, and health-and-nutrition ingredients. The firm organizes its operations into three segments: Water Treatment (potable, wastewater, pool and agricultural water solutions); Industrial (sodium hypochlorite, liquid caustics, acids, phosphates, lactates, custom blends, and repackaging services for sectors such as agriculture, electronics, energy, and pharma); and Health & Nutrition (minerals, vitamins, amino acids, botanicals, sweeteners, enzymes, and formulation services for nutraceutical and functional-food manufacturers). Founded in 1938 and headquartered in Roseville, Minnesota, Hawkins trades under the commodity-chemicals sub-industry classification.

According to the company’s FY 2023 Form 10-K, total revenue was approximately **$1.24 billion**, with the Water Treatment segment contributing roughly **55 %** of sales and delivering an adjusted EBITDA margin near **13 %**. The business generated **$147 million** of adjusted EBITDA and **$119 million** of free cash flow, supporting a dividend yield of about **2.6 %**. Two macro-drivers are especially relevant: (1) rising U.S. and municipal spending on water-infrastructure upgrades, which the U.S. Water Infrastructure Finance and Innovation Act (WIFIA) program estimates will inject **$300 billion** of capital over the next decade, and (2) the continued consumer shift toward functional foods and supplements, a market projected to grow at a **CAGR of ~5 %** through 2028, bolstering demand for Hawkins’ health-and-nutrition ingredients. These figures are taken from the most recent public filings and industry forecasts; actual results may differ if regulatory or supply-chain conditions change.

If you want a deeper, data-driven valuation of HWKN-including scenario analysis of cash-flow sensitivity to water-infrastructure spending and functional-food trends-the ValueRay platform provides a granular, comparable-peer framework to explore.

HWKN Stock Overview

Market Cap in USD	2,670m
Sub-Industry	Commodity Chemicals
IPO / Inception	1993-10-27
Return 12m vs S&P 500	-15.1%
Analyst Rating	4.0 of 5

HWKN Dividends

Metric	Value
Dividend Yield	0.62%
Yield on Cost 5y	2.95%
Yield CAGR 5y	9.97%
Payout Consistency	97.9%
Payout Ratio	18.3%

HWKN Growth Ratios

Metric	Value
CAGR 3y	42.54%
CAGR/Max DD Calmar Ratio	1.22
CAGR/Mean DD Pain Ratio	6.17
Current Volume	173.1k
Average Volume	157.6k

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (83.1m TTM) > 0 and > 6% of Revenue (6% = 62.7m TTM)

FCFTA 0.08 (>2.0%) and ΔFCFTA -3.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 13.49% (prev 12.58%; Δ 0.91pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 122.9m > Net Income 83.1m (YES >=105%, WARN >=100%)

Net Debt (14.5m) to EBITDA (158.1m) ratio: 0.09 <= 3.0 (WARN <= 3.5)

Current Ratio 2.43 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (20.8m) change vs 12m ago -0.07% (target <= -2.0% for YES)

Gross Margin 23.03% (prev 22.76%; Δ 0.27pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 124.9% (prev 135.5%; Δ -10.59pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 12.43 (EBITDA TTM 158.1m / Interest Expense TTM 9.84m) >= 6 (WARN >= 3)

Altman Z'' 4.84

(A) 0.14 = (Total Current Assets 239.6m - Total Current Liabilities 98.6m) / Total Assets 984.2m

(B) 0.49 = Retained Earnings (Balance) 478.3m / Total Assets 984.2m

(D) 1.27 = Book Value of Equity 479.7m / Total Liabilities 378.6m

Total Rating: 4.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 73.08

1. Piotroski 6.0pt

2. FCF Yield 2.93%

3. FCF Margin 7.54%

4. Debt/Equity 0.05

5. Debt/Ebitda 0.09

6. ROIC - WACC (= 3.78)%

7. RoE 17.42%

8. Rev. Trend 65.64%

9. EPS Trend 52.74%

What is the price of HWKN shares?

As of November 22, 2025, the stock is trading at USD 120.17 with a total of 173,090 shares traded.
Over the past week, the price has changed by -5.79%, over one month by -26.25%, over three months by -28.32% and over the past year by -4.99%.

Is HWKN a buy, sell or hold?

Hawkins has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy HWKN.

Strong Buy: 0
Buy: 2
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the HWKN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	188	56.4%
Analysts Target Price	188	56.4%
ValueRay Target Price	148	23.2%

HWKN Fundamental Data Overview November 17, 2025

Market Cap USD = 2.67b (2.67b USD * 1.0 USD.USD)
P/E Trailing = 31.8715
P/E Forward = 31.5457
P/S = 2.5541
P/B = 5.2122
P/EG = 2.2615
Beta = 0.846
Revenue TTM = 1.05b USD
EBIT TTM = 122.4m USD
EBITDA TTM = 158.1m USD
Long Term Debt = 268.3m USD (from longTermDebt, last quarter)
Short Term Debt = 9.81m USD (from shortTermDebt, last quarter)
Debt = 24.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 14.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.68b USD (2.67b + Debt 24.9m - CCE 10.4m)
Interest Coverage Ratio = 12.43 (Ebit TTM 122.4m / Interest Expense TTM 9.84m)
FCF Yield = 2.93% (FCF TTM 78.8m / Enterprise Value 2.68b)
FCF Margin = 7.54% (FCF TTM 78.8m / Revenue TTM 1.05b)
Net Margin = 7.95% (Net Income TTM 83.1m / Revenue TTM 1.05b)
Gross Margin = 23.03% ((Revenue TTM 1.05b - Cost of Revenue TTM 804.6m) / Revenue TTM)
Gross Margin QoQ = 24.12% (prev 24.67%)
Tobins Q-Ratio = 2.73 (Enterprise Value 2.68b / Total Assets 984.2m)
Interest Expense / Debt = 15.37% (Interest Expense 3.83m / Debt 24.9m)
Taxrate = 26.70% (8.23m / 30.8m)
NOPAT = 89.7m (EBIT 122.4m * (1 - 26.70%))
Current Ratio = 2.43 (Total Current Assets 239.6m / Total Current Liabilities 98.6m)
Debt / Equity = 0.05 (Debt 24.9m / totalStockholderEquity, last quarter 507.0m)
Debt / EBITDA = 0.09 (Net Debt 14.5m / EBITDA 158.1m)
Debt / FCF = 0.18 (Net Debt 14.5m / FCF TTM 78.8m)
Total Stockholder Equity = 477.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.45% (Net Income 83.1m / Total Assets 984.2m)
RoE = 17.42% (Net Income TTM 83.1m / Total Stockholder Equity 477.2m)
RoCE = 16.42% (EBIT 122.4m / Capital Employed (Equity 477.2m + L.T.Debt 268.3m))
RoIC = 13.06% (NOPAT 89.7m / Invested Capital 686.9m)
WACC = 9.28% (E(2.67b)/V(2.69b) * Re(9.26%) + D(24.9m)/V(2.69b) * Rd(15.37%) * (1-Tc(0.27)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.15%
[DCF Debug] Terminal Value 70.40% ; FCFE base≈79.9m ; Y1≈66.0m ; Y5≈47.8m
Fair Price DCF = 34.32 (DCF Value 716.9m / Shares Outstanding 20.9m; 5y FCF grow -20.97% → 3.0% )
EPS Correlation: 52.74 | EPS CAGR: 31.66% | SUE: -1.05 | # QB: 0
Revenue Correlation: 65.64 | Revenue CAGR: 9.37% | SUE: -0.34 | # QB: 0

Additional Sources for HWKN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle